According to the Zhongtong Finance APP, Jiayueye Health (00876) surged 1.3 times during trading, with a 118.75% increase, reaching HKD 0.07, and a turnover of HKD 1.9881 million.
It is reported that Jiayueye Health operates primarily through two divisions: the denture manufacturing and trading division, which is engaged in the manufacturing and trading of dentures. Its denture products include dental crowns and bridges, removable partial and complete dentures, implants, and metal crowns; the electronic components manufacturing and trading division, which is engaged in the manufacturing and trading of electronic components. Its electronic component products include connector products, among others.
Jiayueye Health's mid-term performance in 2023 showed that the company achieved a revenue of HKD 92.59 million in the first half of the year, a YoY decrease of approximately 1.48%. The company's equity holders' share of profit amounted to HKD 40.001 million, compared to a loss of HKD 97.017 million in the same period last year. Earnings per share were HKD 0.79. The announcement stated that the company continues to expand its R&amp;D team for dental implants in China and the United States, and that applications for registration of implants in various sizes have been accepted by the National Medical Products Administration.

00876

Jiayueye Health soared 1.3 times in mid-trading, as of the time of writing, with a 118.75% increase, reaching HKD 0.07, with a turnover of HKD 1.9881 million.

Hong Kong Stock Market News | Jiayue Health Soars 1.3 Times in Intraday Trading, Turns Loss into Profit in the First Half of the Year.